Home / Health / The Truth About GLP-1s: Efficacy, Side Effects, Future
The Truth About GLP-1s: Efficacy, Side Effects, Future
5 Mar
Summary
- GLP-1 drugs like Ozempic offer significant weight loss, sometimes rivaling surgery.
- Common side effects include nausea and vomiting; long-term risks are under investigation.
- New oral versions and dual-hormone targeting drugs show promise for greater efficacy.
GLP-1 medications such as Ozempic and Wegovy have revolutionized weight loss treatment, with some patients achieving 15% to 20% body weight reduction, a level previously requiring bariatric surgery. Oral versions are now available and show comparable efficacy to injectables, with newer drugs like tirzepatide targeting multiple hormones for enhanced metabolic benefits. However, the rapid rise of these drugs has also brought potential side effects to light.
Common side effects include nausea, vomiting, and diarrhea. Concerns also exist regarding long-term impacts, including potential links to gallbladder issues, pancreatitis, and osteoporosis. Investigations are ongoing into these risks, alongside new dietary guidelines for users to ensure adequate nutrition and prevent muscle loss. The FDA is also evaluating reports of hair loss and suicidal thoughts associated with some GLP-1 drugs.
Research also indicates GLP-1 drugs may offer broader health benefits beyond weight loss, including improved cardiovascular and kidney health, and potentially reduced cravings for addictive substances. However, maintaining weight loss after discontinuing the medication remains a challenge, with studies suggesting weight regain within approximately 1.5 to 2 years.
